TY - JOUR
KW - CPRD Aurum
KW - clinical practice research datalink
KW - data element presence
KW - indication for use
KW - pharmacoepidemiology
KW - prostatic hyperplasia
AU - R. Persson
AU - K. Hagberg
AU - C. Vasilakis-Scaramozza
AU - E. Yelland
AU - T. Williams
AU - P. Myles
AU - S. Jick
AD - Boston Collaborative Drug Surveillance Program, Lexington, MA, USA.
Clinical Practice Research Datalink, Medicines and Healthcare products Regulatory Agency, London, UK.
Boston University School of Public Health, Boston, MA, USA.
AN - 35535332
BT - Clin Epidemiol
C2 - PMC9078872
DO - 10.2147/clep.s360843
DP - NLM
ET - 2022/05/11
LA - eng
N1 - 1179-1349
Persson, Rebecca
Orcid: 0000-0003-2979-3238
Hagberg, Katrina Wilcox
Orcid: 0000-0002-2407-2995
Vasilakis-Scaramozza, Catherine
Yelland, Eleanor
Williams, Tim
Orcid: 0000-0002-8996-5401
Myles, Puja
Orcid: 0000-0002-8976-890x
Jick, Susan S
Orcid: 0000-0002-2215-1067
Journal Article
Clin Epidemiol. 2022 May 3;14:641-652. doi: 10.2147/CLEP.S360843. eCollection 2022.
PY - 2022
SN - 1179-1349 (Print)1179-1349
SP - 641
EP - 652
T2 - Clin Epidemiol
TI - Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
VL - 14
ER -